Skip to main content
Fig. 2 | Genes and Environment

Fig. 2

From: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer

Fig. 2

Expression of NCAPD2 in pan-cancer. (A) The NCAPD2 mRNA levels in the TIMER1 database. (B) The NCAPD2 mRNA expression in different cancers compared with normal tissues in GEPIA2 databases. (C) The protein expression of NCAPD2 in CTPAC. (D) the expression of NCAPD2 in different cancer stages (*P < 0.05, **P < 0.01, ***P < 0.001)

Back to article page